Pages
Products
Synapsin-GFP AAV (Serotype 8)

Synapsin-GFP AAV (Serotype 8)

Cat.No. :  AAV00099Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 8 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Cat. No. AAV00099Z
Description Synapsin-GFP AAV (Serotype 8) is the serotype 8 AAV which express eGFP under the Synapsin promoter which restricts transgene expression only in neurons.
Reporter GFP
Serotype AAV Serotype 8
Target Gene Synapsin-GFP
Product Type Adeno-associated virus
Application

1. Determination of optimal MOI (multiplicity of infection), administration methods etc.

2. Detection of the infection efficiency of the AAV serotype against a specific cell type or tissue.

3. Using reporter genes to visualize the distribution and expression of AAV vectors in live animals, helping assess the biodistribution and persistence of gene delivery.

Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

Over the past 20 years, adeno-associated viruses (AAVs) have been extensively studied as potential gene therapy vectors to deliver corrective genes into cells or tissues of target organisms. AAVs belong to the genus Dependovirus of the family Parvoviridae and require a helper virus such as adenovirus or herpes virus to cause effective infection. The non-pathogenicity of AAVs and the ability to package and deliver foreign DNA to target cells make them ideal viral vectors for gene delivery. To date, 11 different serotypes have been found in primates, AAV serotypes 1 (AAV1) to AAV11, and many more recombinant isolates have been found in different tissues of humans and non-human primates. AAV8 was isolated from rhesus macaque tissues and has a high degree of homology to other AAVs, but it has been reported to have a much higher hepatocyte transduction efficiency than all other AAVs tested to date. For example, in a mouse model, AAV8 has been reported to have a liver transduction efficiency that is approximately 50 times higher than that of AAV2. This observation, coupled with the low reactivity to human AAV antibodies, has led to efforts to develop AAV8 as a viral vector for liver-directed gene therapy applications. Long-term correction of hemophilia A, familial hypercholesterolemia, and glycogen storage disease type II using AAV8 as a gene therapy vector has been reported in mouse models. In addition, AAV8 has been successfully used for liver-directed gene therapy in canine models and has been shown to effectively cross the vascular barrier to achieve systemic gene transfer in skeletal and cardiac muscle in mice and hamsters.

Regulating neuro-metabolic-inflammatory responses is essential for maintaining physiological homeostasis. However, the molecular mechanisms that coordinate neural, metabolic, and inflammatory responses are largely unknown. Here, researchers show that semaphorin 6D (SEMA6D) coordinates anxiety, metabolic, and inflammatory outputs in the amygdala by maintaining synaptic homeostasis. Using a genome-wide approach, researchers identify SEMA6D as a pleiotropic gene underlying human psychiatric and metabolic traits. Sema6d deficiency increases anxiety in mice. When fed a high-fat diet, Sema6d−/− mice exhibit reduced adiposity and enhanced myelopoiesis compared with control mice, due to higher sympathetic activity through β3-adrenergic receptors. Genetic manipulations and spatial and single-nucleus transcriptomics reveal that SEMA6D in amygdala interneurons is responsible for regulating anxiety and autonomic responses. Mechanistically, SEMA6D is required for synaptic maturation and γ-aminobutyric acid transmission. These results suggest that SEMA6D is important for the normal functioning of the neural circuits in the amygdala, coupling emotional, metabolic, and inflammatory responses.

Here, to directly determine whether amygdalar SEMA6D is involved in the regulation of anxiety and systemic metabolism, researchers stereotaxically injected AAV8-hSyn-GFP or AAV8-hSyn-Cre-GFP into the CeA of Sema6dfl/fl mice. CeA-specific SEMA6D deletion reduced exploration time in the OF test and mitigated HFD-induced obesity, indicating that amygdala SEMA6D is responsible for the regulation of anxiety and systemic metabolism (Figures 1I-1K).

Sema6dfl/fl mice were bilaterally injected with AAV8-hSyn-GFP or AAV8-hSyn-Cre-GFP into the CeA.Figure 1. Sema6dfl/fl mice were bilaterally injected with AAV8-hSyn-GFP or AAV8-hSyn-Cre-GFP into the CeA. (Nakanishi Y, et al., 2024)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
High-quality

After using Synapsin-GFP AAV (Serotype 8) in several rounds of experiments, I can confidently say that its performance is remarkably reliable.

Canada

03/29/2022

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction